MedStar Georgetown Cancer Institute at MedStar Washington Hospital Center ( Site 0026) is a clinical research site located in Washington D.C., District of Columbia, United States 20010.
Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.
MedStar Georgetown Cancer Institute at MedStar Washington Hospital Center ( Site 0026) has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Castration-Resistant Prostatic Cancer, Metastasis.
Sponsors: Merck Sharp & Dohme LLC.
Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
MedStar Georgetown Cancer Institute at MedStar Washington Hospital Center ( Site 0026) has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
MedStar Georgetown Cancer Institute at MedStar Washington Hospital Center ( Site 0026) has 1 clinical trials on record, with 1 currently active. Their work covers Castration-Resistant Prostatic Cancer, Metastasis.
MedStar Georgetown Cancer Institute at MedStar Washington Hospital Center ( Site 0026) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.